IL160438A0 - Pharmaceutical compositions containing an angiotensin ii receptor antagonist - Google Patents
Pharmaceutical compositions containing an angiotensin ii receptor antagonistInfo
- Publication number
- IL160438A0 IL160438A0 IL16043802A IL16043802A IL160438A0 IL 160438 A0 IL160438 A0 IL 160438A0 IL 16043802 A IL16043802 A IL 16043802A IL 16043802 A IL16043802 A IL 16043802A IL 160438 A0 IL160438 A0 IL 160438A0
- Authority
- IL
- Israel
- Prior art keywords
- angiotensin
- pharmaceutical compositions
- compositions containing
- receptor antagonist
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001257435 | 2001-08-28 | ||
| PCT/JP2002/008629 WO2003020315A1 (fr) | 2001-08-28 | 2002-08-27 | Compositions medicinales contenant un antagoniste du recepteur d'angiotensine ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160438A0 true IL160438A0 (en) | 2004-07-25 |
Family
ID=19085097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16043802A IL160438A0 (en) | 2001-08-28 | 2002-08-27 | Pharmaceutical compositions containing an angiotensin ii receptor antagonist |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040198788A1 (es) |
| EP (1) | EP1421953A4 (es) |
| KR (1) | KR20040032969A (es) |
| CN (1) | CN1589154A (es) |
| AU (1) | AU2002328569B9 (es) |
| BR (1) | BR0212254A (es) |
| CA (1) | CA2459017A1 (es) |
| CO (1) | CO5560583A2 (es) |
| HU (1) | HUP0401696A2 (es) |
| IL (1) | IL160438A0 (es) |
| MX (1) | MXPA04001878A (es) |
| NO (1) | NO20041291L (es) |
| NZ (1) | NZ531346A (es) |
| PL (1) | PL368843A1 (es) |
| RU (1) | RU2004105965A (es) |
| WO (1) | WO2003020315A1 (es) |
| ZA (1) | ZA200401603B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1604664A4 (en) * | 2003-01-31 | 2006-12-27 | Sankyo Co | MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND BLOOD HIGH PRESSURE |
| WO2007086980A2 (en) * | 2005-11-10 | 2007-08-02 | Duke University | Methods of determining the risk of developing coronary artery disease |
| KR101345876B1 (ko) * | 2012-01-31 | 2013-12-30 | 인제대학교 산학협력단 | 피마사르탄을 함유하는 세포, 조직 또는 장기 보존용 조성물 |
| CN112979617A (zh) * | 2019-12-17 | 2021-06-18 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种厄贝沙坦哌嗪盐及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8705837A1 (es) * | 1985-01-10 | 1987-05-16 | Tanabe Seiyaku Co | Un procedimiento para la preparacion de derivados de naftaleno. |
| US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| DE69016335T2 (de) * | 1989-10-06 | 1995-06-01 | Fujirebio Kk | Pantothensäure Derivate. |
| DK0443983T3 (da) * | 1990-02-19 | 1996-03-18 | Ciba Geigy Ag | Acrylforbindelser |
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| GB9025509D0 (en) * | 1990-11-23 | 1991-01-09 | Fujisawa Pharmaceutical Co | New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
| DE69119434T2 (de) * | 1990-11-26 | 1996-09-12 | Taisho Pharma Co Ltd | Anilidderivat |
| US5614519A (en) * | 1991-02-06 | 1997-03-25 | Karl Thomae Gmbh | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists |
| IE920540A1 (en) * | 1991-02-21 | 1992-08-26 | Sankyo Co | 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| JP3720395B2 (ja) * | 1994-09-20 | 2005-11-24 | 京都薬品工業株式会社 | 新規ヘテロ環誘導体、その製造方法およびその医薬用途 |
| US6063806A (en) * | 1995-10-05 | 2000-05-16 | Kyoto Pharmaceutical Industries, Ltd. | Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors |
| FR2741619B1 (fr) * | 1995-11-28 | 1998-02-13 | Pf Medicament | Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique |
| CA2197364A1 (en) * | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Phenol compound and process for preparing the same |
| JPH11228416A (ja) * | 1997-10-23 | 1999-08-24 | Takeda Chem Ind Ltd | 脂質低下剤 |
| US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| DE19916108C1 (de) * | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
| WO2002087580A1 (fr) * | 2001-04-25 | 2002-11-07 | Takeda Chemical Industries, Ltd. | Promoteurs d'expression d'abc |
-
2002
- 2002-08-27 NZ NZ531346A patent/NZ531346A/en unknown
- 2002-08-27 IL IL16043802A patent/IL160438A0/xx unknown
- 2002-08-27 BR BR0212254-5A patent/BR0212254A/pt not_active IP Right Cessation
- 2002-08-27 RU RU2004105965/15A patent/RU2004105965A/ru not_active Application Discontinuation
- 2002-08-27 EP EP02762874A patent/EP1421953A4/en not_active Withdrawn
- 2002-08-27 CN CNA028213645A patent/CN1589154A/zh active Pending
- 2002-08-27 MX MXPA04001878A patent/MXPA04001878A/es unknown
- 2002-08-27 HU HU0401696A patent/HUP0401696A2/hu unknown
- 2002-08-27 WO PCT/JP2002/008629 patent/WO2003020315A1/ja not_active Application Discontinuation
- 2002-08-27 KR KR10-2004-7002806A patent/KR20040032969A/ko not_active Application Discontinuation
- 2002-08-27 PL PL02368843A patent/PL368843A1/xx not_active Application Discontinuation
- 2002-08-27 CA CA002459017A patent/CA2459017A1/en not_active Abandoned
- 2002-08-27 AU AU2002328569A patent/AU2002328569B9/en not_active Ceased
-
2004
- 2004-02-26 US US10/789,340 patent/US20040198788A1/en not_active Abandoned
- 2004-02-26 ZA ZA200401603A patent/ZA200401603B/en unknown
- 2004-03-16 CO CO04024652A patent/CO5560583A2/es unknown
- 2004-03-26 NO NO20041291A patent/NO20041291L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200401603B (en) | 2004-10-19 |
| AU2002328569B9 (en) | 2005-10-27 |
| EP1421953A4 (en) | 2004-09-15 |
| CN1589154A (zh) | 2005-03-02 |
| BR0212254A (pt) | 2004-10-19 |
| PL368843A1 (en) | 2005-04-04 |
| NO20041291L (no) | 2004-05-27 |
| US20040198788A1 (en) | 2004-10-07 |
| CA2459017A1 (en) | 2003-03-13 |
| KR20040032969A (ko) | 2004-04-17 |
| AU2002328569B2 (en) | 2005-09-22 |
| NZ531346A (en) | 2005-10-28 |
| MXPA04001878A (es) | 2004-06-15 |
| EP1421953A1 (en) | 2004-05-26 |
| WO2003020315A1 (fr) | 2003-03-13 |
| NO20041291D0 (no) | 2004-03-26 |
| CO5560583A2 (es) | 2005-09-30 |
| HUP0401696A2 (hu) | 2004-11-29 |
| RU2004105965A (ru) | 2005-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL187604A0 (en) | Pharmaceutical compositions containing an interleukin-6 antagonist | |
| IL169575A0 (en) | Calcium-sensing receptor antagonist compounds and pharmaceutical compositions containing the same | |
| IL159725A0 (en) | Pharmaceutical compositions containing benzimidazole derivatives | |
| IL174909A (en) | Pharmaceutical compositions containing an interleukin-6 antagonist | |
| IL176122A0 (en) | Pharmaceutical compositions containing an interleukin-6 antagonist | |
| HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
| HK1079704A1 (zh) | 用於醫藥用途的固體粒子抗真菌組合物 | |
| HUP0203870A3 (en) | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist | |
| EG24194A (en) | 5ht-a-partial agonist pharmaceutical compositions | |
| GB0111597D0 (en) | Pharmaceutical compositions | |
| HUP0302382A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them | |
| HK1059575A1 (en) | Nmda receptor agonist pharmaceutical compositions | |
| IL160715A0 (en) | Pharmaceutical compositions containing an a1 adenosine receptor antagonist | |
| AU2002365655A1 (en) | 5-ht7 receptor antagonists | |
| HUP0302003A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them | |
| EP1359915A4 (en) | UROTENSIN-II RECEPTOR ANTAGONISTS | |
| HUP0302614A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them | |
| IL160438A0 (en) | Pharmaceutical compositions containing an angiotensin ii receptor antagonist | |
| IL157398A0 (en) | Pharmaceutical compositions comprising ccr5 antagonists | |
| AU2002328569A1 (en) | Medicinal compositions containing angiotensin II receptor antagonist | |
| GB2382302B (en) | Pharmaceutical compositions | |
| AU2002338040A1 (en) | Receptor antagonist | |
| GB0126732D0 (en) | Pharmaceutical compositions | |
| IL165716A0 (en) | Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists | |
| IL164188A0 (en) | Pharmaceutical compositions containing entecavir |